United Therapeutics Corporation (UTHR) /
The debt of United Therapeutics Corporation over the past 10 years
Chart United Therapeutics Corporation: liquid cash, total debt, net cash, fiscal 2016–2025 Open the chart →At the end of fiscal 2025, the latest fiscal year on file, United Therapeutics Corporation had liquid cash of $2.92B and total debt of $0: net cash of $2.92B. It had more liquid cash than debt at all 10 year-ends shown. Total debt was highest at the end of fiscal 2019 ($850M) and lowest at the end of fiscal 2016 ($0).
Year by year
| Fiscal year | Liquid cash | Total debt* | Net cash* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $2.92B* | $0 | $2.92B |
| 2024ended Dec 31, 2024 | $3.27B* | $300M | $2.97B |
| 2023ended Dec 31, 2023 | $2.99B* | $700M | $2.29B |
| 2022ended Dec 31, 2022 | $2.84B* | $800M | $2.04B |
| 2021ended Dec 31, 2021 | $1.93B* | $800M | $1.13B |
| 2020ended Dec 31, 2020 | $1.83B* | $800M | $1.03B |
| 2019ended Dec 31, 2019 | $1.49B* | $850M | $635.9M |
| 2018ended Dec 31, 2018 | $1.42B* | $250M | $1.17B |
| 2017ended Dec 31, 2017 | $927.4M* | $250M | $677.4M |
| 2016ended Dec 31, 2016 | $1.05B* | $0 | $1.05B |
Fiscal years as United Therapeutics Corporation reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on United Therapeutics Corporation
- The revenue of United Therapeutics Corporation
- The profitability of United Therapeutics Corporation
- The cash flow of United Therapeutics Corporation
- All of United Therapeutics Corporation's financials, charted
Companies of a similar size
- LHLABCORP HOLDINGS INC.
- ULTAULTA BEAUTY, INC.
- DGXQuest Diagnostics Inc
- DOVDOVER Corp
- CNPCENTERPOINT ENERGY INC
Not investment advice. This page shows what United Therapeutics Corporation filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.